<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Advances in Molecular Oncology</journal-id><journal-title-group><journal-title xml:lang="en">Advances in Molecular Oncology</journal-title><trans-title-group xml:lang="ru"><trans-title>Успехи молекулярной онкологии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2313-805X</issn><issn publication-format="electronic">2413-3787</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">203</article-id><article-id pub-id-type="doi">10.17650/2313-805X-2019-6-1-18-36</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>REVIEW ARTICLES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОБЗОРНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Modulation of the formation of active forms of nitrogen by ingredients of plant products in the inhibition of carcinogenesis</article-title><trans-title-group xml:lang="ru"><trans-title>Модулирование образования активных форм азота ингредиентами растительных продуктов при ингибировании канцерогенеза</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Deryagina</surname><given-names>V. P.</given-names></name><name xml:lang="ru"><surname>Дерягина</surname><given-names>В. П.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>24 Kashirskoe Shosse, Moscow 115478.</p></bio><bio xml:lang="ru"><p>Дерягина Валентина Петровна.</p><p>115478 Москва, Каширское шоссе, 24.</p></bio><email>derygina@inbox.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Reutov</surname><given-names>V. P.</given-names></name><name xml:lang="ru"><surname>Реутов</surname><given-names>В. П.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>5a Butlerova St., Mosсow 117485.</p></bio><bio xml:lang="ru"><p>117485 Москва, ул. Бутлерова, 5а.</p></bio><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia</institution></aff><aff><institution xml:lang="ru">Национальный медицинский исследовательский центр онкологии им. Н.Н. Блохина Минздрава России</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Institute of Higher Nervous Activity and Neurophysiology of the Russian Academy of Sciences</institution></aff><aff><institution xml:lang="ru">Институт высшей нервной деятельности и нейрофизиологии РАН</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2019-01-15" publication-format="electronic"><day>15</day><month>01</month><year>2019</year></pub-date><volume>6</volume><issue>1</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>18</fpage><lpage>36</lpage><history><date date-type="received" iso-8601-date="2019-04-27"><day>27</day><month>04</month><year>2019</year></date><date date-type="accepted" iso-8601-date="2019-04-27"><day>27</day><month>04</month><year>2019</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2019, Deryagina V.P., Reutov V.P.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2019, Дерягина В.П., Реутов В.П.</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="en">Deryagina V.P., Reutov V.P.</copyright-holder><copyright-holder xml:lang="ru">Дерягина В.П., Реутов В.П.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://umo.abvpress.ru/jour/article/view/203">https://umo.abvpress.ru/jour/article/view/203</self-uri><abstract xml:lang="en"><p>The review analyzes literature data and the results of our own research on the role of reactive nitrogen species (NO, NO<sub>2</sub>, N<sub>2</sub>O<sub>3</sub>) in the initiation and progression of tumors. The possibility of modulating the activity of inducible NO synthase by the biologically active components of plant products and their effect on carcinogenesis is analyzed. Possible mechanisms of the ambiguous action of NO and its metabolic products in the mechanisms of carcinogenesis are discussed. The generalization and analysis of these data allowed us to formulate some principles for the use of substances that modulate the activity of inducible NO synthase and affect the formation of NO and its metabolic products in inhibiting carcinogenesis.</p></abstract><trans-abstract xml:lang="ru"><p>В обзоре анализируются данные литературы и результаты собственных исследований о роли активных форм азота (NO, NO<sub>2</sub>, N<sub>2</sub>O<sub>3</sub>) в инициации и прогрессии опухолей. Анализируется возможность модуляции активности индуцибельной NO-синтазы биологически активными компонентами растительных продуктов и их влияние на канцерогенез. Обсуждаются возможные механизмы неоднозначного действия NO и продуктов его метаболизма в канцерогенезе. Обобщение и анализ этих данных позволили сформулировать некоторые принципы применения веществ, модулирующих активность индуцибельной NO-синтазы и влияющих на образование NO и продуктов его метаболизма при ингибировании канцерогенеза.</p></trans-abstract><kwd-group xml:lang="en"><kwd>nitric oxide</kwd><kwd>active forms of nitric oxide</kwd><kwd>inducible NO-synthase</kwd><kwd>cycle of nitric oxide</kwd><kwd>carcinogenesis</kwd><kwd>biologically active component of plant products</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>оксид азота</kwd><kwd>активные формы оксида азота</kwd><kwd>индуцибельная NO-синтаза</kwd><kwd>цикл оксида азота</kwd><kwd>канцерогенез</kwd><kwd>биологически активный компонент растительных продуктов</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Coussens L.M., Werb Z. Inflammation and cancer. Nature 2002;420(6917): 860-7. DOI: 10.1038/nature01322. PMID: 12490959.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Vannini F., Kashfi Kh., Nath N. The dual role of iNOS in cancer. Redox Biol 2015;6:334-43. DOI: 10.1016/j.redox.2015.08.009. PMID: 26335399.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Thomas D.D., Ridnour L.A., Isenberg J.S. et al. The Chemical biology of nitric oxide. Implication in Cellular Signaling. Free Radic Biol Med 2008;45(1):18-316. DOI: 10.1016/j.freeradbiomed.2008.03.020. PMID: 18439435.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Benetou V., Orfanos P., Lagiou P. et al. Vegetables and fruits in relation to cancer risk: evidence from the Greek EPIC cohort study. Cancer Epidemiol Biomarkers Prev 2008;17(2):387-92. DOI: 10.1158/1055-9965.EPI-07-2665. PMID: 18268122.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Kaur V., Kumar M., Kumar A. et al. Pharmacotherapeutic potencial of phytochemicals: implications in cancer chemoprevention and future perspectives. Biomed Pharmacother 2018;97:564-86. DOI: 10.1016/j.biopha.2017.10.124. PMID: 29101800.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Weng Ch.J., Yen G.Ch. Chemopreventive effects of dietary phytochemicals against cancer invasion and metastasis: phenolic acids, monophenol, polyphenol, and their derivatives. Cancer Treat Rev 2012;38(1):76—87. DOI: 10.1016/j.ctrv.2011.03.001. PMID: 21481535.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Steward W.P., Brown K. Cancer chemoprevention: a rapidly evolving field. British J Cancer 2013;109(1):1-7. DOI: 10.1038/bjc.2013.280. PMID: 23736035.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>IARC monographs. Ingested nitrate and nitrite, and cyanobacterial peptide toxins. Vol. 94. Lyon, 2010. Pp. 45-325.</mixed-citation></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">Deryagina V.P., Mashkovtsev Yu.V., Ilnitsky A.P. Experimental study of the functional activity of neutrophils and macrophages under conditions of exposure to sodium nitrite. Biomeditsinskaya khimiya = Biomedical Chemistry 2003;49(1):19—26. (In Russ.).</mixed-citation><mixed-citation xml:lang="ru">Дерягина В.П., Машковцев Ю.В., Ильницкий А.П. Экспериментальное изучение функциональной активности нейтрофилов и макрофагов в условиях воздействия нитрита натрия. Биомедицинская химия 2003;49(1):19-26.</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">Harmful substances in industry. Vol. 3. Leningrad: Khimiya, 1977. 607 p. (In Russ.).</mixed-citation><mixed-citation xml:lang="ru">Вредные вещества в промышленности. Том 3. Ленинград: Химия, 1977. 607 с.</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">Zhukova G.F., Arkhipov G.N., Ivashkina A.S., Pimenova V.V. The carcinogenic effect of precursors when administered to mice in conjunction with inhibitors. In: The biological effect of carcinogenic nitroso compounds. Pskov. L.: b. i., 1980. Pp. 55-57. (In Russ.).</mixed-citation><mixed-citation xml:lang="ru">Жукова Г.Ф., Архипов Г.Н., Ивашкина А.С., Пименова В.В. Канцерогенное действие предшественников при введении внутрь мышам совместно с ингибиторами. В кн.: Биологический эффект канцерогенных нитрозосоединений. Псков. Л.: б. и., 1980. С. 55-57.</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">Yurchenko V.A., Ilnitsky A.P., Ermilov I.B. et al. Formation of carcinogenic nitrosamines from a small amount of precursors in human gastric juice. Eksperimental’naya onkologiya = Experimental Oncology 1990;12(2):24—6. (In Russ.).</mixed-citation><mixed-citation xml:lang="ru">Юрченко В.А., Ильницкий А.П., Ермилов И.Б. и др. Образование канцерогенных нитрозаминов из малого количества предшественников в желудочном соке человека. Экспериментальная онкология 1990;12(2):24—6.</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">Reutov V.P., Sorokina E.G., Okhotin V.E., Kositsyn N.S. Cyclic transformations of nitric oxide in mammals. Moscow: Nauka, 1997. 156 p. (In Russ.).</mixed-citation><mixed-citation xml:lang="ru">Реутов В.П., Сорокина Е.Г., Охотин В.Е., Косицын Н.С. Циклические превращения оксида азота в организме млекопитающих. М.: Наука, 1997. 156 c.</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">Zhang X., Lin Y., Gillies R.J. Tumor pH and its measurement. J Nucl Med 2010;51(8):1167-70. DOI: 10.2967/jnumed.109.068981. PMID: 20660380.</mixed-citation><mixed-citation xml:lang="ru">Zhang X., Lin Y., Gillies R.J. Tumor pH and its measurement. J Nucl Med 2010;51(8):1167—70. DOI: 10.2967/jnumed.109.068981. PMID: 20660380.</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><mixed-citation>Ilnitsky A.P., Reutov V.P., Ryzhova N.I. et al. Urethane-induced pulmonary adenoma and Rausher’s leukemia modified by sodium nitrite in mice: a possible role for nitric oxide and nitric dioxide. Exp Oncol 1997;19:101-9.</mixed-citation></ref><ref id="B16"><label>16.</label><citation-alternatives><mixed-citation xml:lang="en">Ilnitsky A.P., Ryzhova N.I., Chudina A.P. et al. The potentiating effect of sodium nitrite on the development of spontaneous and 1,2-dimethylhydrazine-induced tumors in F1 male mice(C57BlxCBA). Voprosy onkologii = Oncology Issues 2004;50(6):683-8 (In Russ.).</mixed-citation><mixed-citation xml:lang="ru">Ильницкий А.П., Рыжова Н.И., Чудина А.П. и др. Потенцирующее действие нитрита натрия на развитие спонтанных и индуцированных 1,2-диметилгидразином опухолей у мышей-самцов F1 (C57BlxCBA). Вопросы онкологии 2004;50(6):683-8.</mixed-citation></citation-alternatives></ref><ref id="B17"><label>17.</label><citation-alternatives><mixed-citation xml:lang="en">Ilnitsky A.P., Yurchenko V.A., Zhukova G.F., Ermilov V.B. Assessment of the carcinogenic risk of low doses of nitrite. Voprosy pitaniya = Nutrition Issues 1989;35(7):843-8. (In Russ.).</mixed-citation><mixed-citation xml:lang="ru">Ильницкий А.П., Юрченко В.А., Жукова Г.Ф., Ермилов В.Б. Оценка степени канцерогенной опасности малых доз нитритов. Вопросы питания 1989;35(7):843-8.</mixed-citation></citation-alternatives></ref><ref id="B18"><label>18.</label><citation-alternatives><mixed-citation xml:lang="en">Reutov V.P. The cycle of nitric oxide in mammals and the principle of cyclicity. Biokhimiya = Biochemistry 2002;67(3):353-76. (In Russ.).</mixed-citation><mixed-citation xml:lang="ru">Реутов В.П. Цикл оксида азота в организме млекопитающих и принцип цикличности. Биохимия 2002;67(3):353-76.</mixed-citation></citation-alternatives></ref><ref id="B19"><label>19.</label><citation-alternatives><mixed-citation xml:lang="en">Reutov V.P., Azhipa Ya.I., Kayushin L.P. The study by the method of electron paramagnetic resonance products of the interaction of nitrogen oxides with some organic compounds. Byulleten’ eksperimental’noy biologii i meditsiny = Bulletin of Experimental Biology and Medicine 1978;9:299-301. (In Russ.).</mixed-citation><mixed-citation xml:lang="ru">Реутов В.П., Ажипа Я.И., Каюшин Л.П. Изучение методом электронного парамагнитного резонанса продуктов взаимодействия окислов азота с некоторыми органическими соединениями. Бюллетень экспериментальной биологии и медицины 1978;9:299-301.</mixed-citation></citation-alternatives></ref><ref id="B20"><label>20.</label><citation-alternatives><mixed-citation xml:lang="en">Reutov V.P., Azhipa Ya.I., Kayushin L.P. The study of paramagnetic centers arising from the interaction of nitrogen dioxide with oleic acid and tyrosine. Doklady Akademii nauk SSSR = Report Academy of Sciences of the USSR 1978;241(6):1375-7. (In Russ.).</mixed-citation><mixed-citation xml:lang="ru">Реутов В.П., Ажипа Я.И., Каюшин Л.П. Исследование парамагнитных центров, возникающих при взаимодействии двуокиси азота с олеиновой кислотой и тирозином. Доклады Академии наук СССР 1978;241(6):1375-7.</mixed-citation></citation-alternatives></ref><ref id="B21"><label>21.</label><citation-alternatives><mixed-citation xml:lang="en">Reutov V.P., Orlov S.N. The physiological significance of guanylate cyclase and the role of nitric oxide and nitro compounds in the regulation of the activity of this enzyme. Fiziologiya cheloveka = Human Physiology 1993;19(1):124—37. (In Russ.).</mixed-citation><mixed-citation xml:lang="ru">Реутов В.П., Орлов С.Н. Физиологическое значение гуанилатциклазы и роль окиси азота и нитросоединений в регуляции активности этого фермента. Физиология человека 1993;19(1):124-37.</mixed-citation></citation-alternatives></ref><ref id="B22"><label>22.</label><mixed-citation>Ignarro L.J., Buga G.M., Wood K.S. et al. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 1987;84:9265-9. PMID: 2827174.</mixed-citation></ref><ref id="B23"><label>23.</label><citation-alternatives><mixed-citation xml:lang="en">Forstermann U., Sessa W.C. Nitric oxide synthases: regulation and function. Eur Heart J 2012;33(7):829-37. DOI: 10.1093/eurheartj/ehr304. PMID: 21890489.</mixed-citation><mixed-citation xml:lang="ru">Forstermann U., Sessa W.C. Nitric oxide synthases: regulation and function. Eur Heart J 2012;33(7):829—37. DOI: 10.1093/eurheartj/ehr304. PMID: 21890489.</mixed-citation></citation-alternatives></ref><ref id="B24"><label>24.</label><citation-alternatives><mixed-citation xml:lang="en">Tendler D.S., Bao C., Wang T. et al. Intersection of interferon and hypoxia signal transduction pathways in nitric oxide-induced tumor apoptosis. Cancer Res 2001;61(9):3682-8. PMID: 11325839.</mixed-citation><mixed-citation xml:lang="ru">Tendler D.S., Bao C., Wang T. et al. Intersection of interferon and hypoxia signal transduction pathways in nitric oxide-induced tumor apoptosis. Cancer Res 2001;61(9):3682—8. PMID: 11325839.</mixed-citation></citation-alternatives></ref><ref id="B25"><label>25.</label><mixed-citation>Nathan C.F., Hibbs J.B. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr Opin Immunol 1991;3(1):65-70. PMID: 1711326.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Alderton W.K., Cooper C.E., Knowles R.G. Nitric oxide synthases: structure, function and inhibition. Biochem J 2001;357: 593-615. PMID: 11463332.</mixed-citation></ref><ref id="B27"><label>27.</label><citation-alternatives><mixed-citation xml:lang="en">Zaporozhan V.N., Gozhenko A.I., Korneenko T.V., Dubinina V.G. Biological E activity of nitric oxide in the mechanisms of tumor growth. Uspekhi fiziologicheskikh nauk = Advances in Physiological Sciences 2004;35(1):66-82. (In Russ.).</mixed-citation><mixed-citation xml:lang="ru">Запорожан В.Н., Гоженко А.И., Корнеенко Т.В., Дубинина В.Г. Биологическая активность оксида азота в механизмах опухолевого роста. Успехи физиологических наук 2004;35(1): 66-82.</mixed-citation></citation-alternatives></ref><ref id="B28"><label>28.</label><citation-alternatives><mixed-citation xml:lang="en">Zenkov N.K., Men’shchikova E.B., Reutov V.P. NO synthase is normal and in the pathology of various genesis. Vestnik RAMN = Bulletin of RAMS 2000;4:30-4. (In Russ.).</mixed-citation><mixed-citation xml:lang="ru">Зенков Н.К., Меньщикова Е.Б., Реутов В.П. NO-синтазы в норме и при патологии различного генеза. Вестник РАМН 2000;4:30-4.</mixed-citation></citation-alternatives></ref><ref id="B29"><label>29.</label><mixed-citation>Deryagina V.P., Ryzhova N.I., Krivosheeva L.V., Golubeva I.S. Formation of nitric oxide metabolites during growth of transplanted tumors with different metastatic potential. Biochemistry (Moscow). Suppl. Series B: Biomed Chemistry 2015;9(2):130-6. DOI: 10.1134/S1990750815020055.</mixed-citation></ref><ref id="B30"><label>30.</label><citation-alternatives><mixed-citation xml:lang="en">Kondakova I.V., Zagrebelnaya G.V., Reutov V.P. Effect of peroxide radicals and nitric oxide on the proliferating activity of tumor cells. Izvestiya Natsional’noy akademii nauk Belarusi. Ceriya medico-biologicheskikh nauk = News of the National Academy of Sciences of Belarus. Biomedical Science Series 2003;1:78-82. (In Russ.).</mixed-citation><mixed-citation xml:lang="ru">Кондакова И.В., Загребельная Г.В., Реутов В.П. Влияние пероксидных радикалов и оксида азота на пролиферирующую активность опухолевых клеток. Известия Национальной академии наук Беларуси. Серия медико-биологических наук 2003;1:78-82.</mixed-citation></citation-alternatives></ref><ref id="B31"><label>31.</label><citation-alternatives><mixed-citation xml:lang="en">Reutov V.P. Nitric oxide cycle in mammals and the cyclicity principle. Biochemistry (Moscow) 2002;67(3):293-311. PMID: 11970729.</mixed-citation><mixed-citation xml:lang="ru">Reutov V.P. Nitric oxide cycle in mammals and the cyclicity principle. Biochemistry (Moscow) 2002;67(3):293—311. PMID: 11970729.</mixed-citation></citation-alternatives></ref><ref id="B32"><label>32.</label><mixed-citation>Bonavida B., Khineche S., Huerta-Yepez S., Garban H. Therapeutic potential of nitric oxide in cancer. Drug Resist Updates 2006;9(3):157-73. DOI: 10.1016/j.drup.2006.05.003. PMID: 16822706.</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Pautz A., Art J., Hahn S. Regulation of the expression of inducible nitric oxide synthase. Nitric Oxide 2010;23:75-93. DOI: 10.1016/j.niox.2010.04.007. PMID: 20438856.</mixed-citation></ref><ref id="B34"><label>34.</label><citation-alternatives><mixed-citation xml:lang="en">Deryagina V.P. The formation of free radical compounds under the action of sodium nitrite on the organism of animals and in vitro. Toksikologicheskiy vestnik = Toxicological messenger 2003;6:20-5. (In Russ.).</mixed-citation><mixed-citation xml:lang="ru">Дерягина В.П. Образование свободно-радикальных соединений при действии условиях in vitro. Токсикологический вестник 2003;6:20-5.</mixed-citation></citation-alternatives></ref><ref id="B35"><label>35.</label><mixed-citation>Menshikova E.B., Zenkov N.K., Reutov V.P. Nitric oxide and NO-synthase in mammals in different functional states. Biochemistry (Moscow) 2000;65(4): 409-26.</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Reutov V.P., Kayushin L.P., Sorokina E.G. Physiological role of nitric oxide cycle in human and animal organism. Hum Physiol 1994;20:219-29.</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Friebe A., Koesling D. Regulation of nitric oxide-sensitive guanylyl cyclase. Circ Res 2003;93:96-105. DOI: 10.1161/01.RES.0000082524.34487.31. PMID: 12881475.</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Dangel O., Mergia E., Karlisch K. et al. Nitric oxide-sensitive guanylyl cyclase is the only nitric oxide receptor mediating platelet inhibition. J Thromb Haemost JTH 2010;8:1343-52. DOI: 10.1111/j.1538-7836.2010.03806.x. PMID: 20149081.</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Heinrich T.A., da Silva R.S., Miranda K.M. et al. Biological nitric oxide signaling: chemistry and terminology. Brit J Pharmac 2013;169(7):1417-29. DOI: 10.1111/bph.122. PMID: 23617570.</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Wink D.A., Kaspizak K.S., Maragos C.M. et al. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science 1991;254(5034): 1001-3. PMID: 1948068.</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>Azad N., Vallyathan V., Wang L. et al. S-nitrosylation of Bcl-2 inhibits its ubiquitin-proteasomal degradation. A novel antiapoptic mechanism that suppressed apoptosis. J Biol Chem 2006;281:34124-34. DOI: 10.1074/jbc.M602551200. PMID: 16980304.</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>Wright C., Iyer A.K., Kulkarni Y., Azad N. S-Nitrosylation of Bcl-2 negatively affects autophagy in lung epithelial cells. J Cell Biochem 2016;117(2):521-32. DOI: 10.1002/jcb.25303. PMID: 26241894.</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>Raines K.W., Bonini M.G., Campbell S.L. Nitric Oxide cell signaling: S-nitrosation of Ras superfamily GTPases. Cardiovasc Res 2007;75(2):229-39. DOI: 10.1016/j.cardiores.2007.04.013. PMID: 17559822.</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>Lee S.Y., Rim Y., McPherson D.D. et al. A novel liposomal nanomedicine for nitric oxide delivery and breast cancer treatment. Biomed Mater Eng 2014;24(1):61-7. DOI: 10.3233/BME-130784. PMID: 24211883.</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>Ambs S., Merriam W.G., Bennett W.P. et al. Frequent nitric oxide synthase-2expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression. Cancer Res 1998;58(2):334-41. PMID: 9443414.</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>Gallo O., Masini E., Morbidelli L. et al. Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer. J Natl Cancer Inst 1998;90(8):587-96. PMID: 9554441.</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>Thomas D.D., Espey M.G., Ridnour L.A. et al. Hypoxic inducible factor 1 alpha, extracellular signal-regulated kinase, and p53 are regulated by distinct threshold concentrations of nitric oxide. Proc Natl Acad Sci USA 2004;101(24):8894-9. DOI: 10.1073/pnas.0400453101. PMID: 15178764.</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation>Espey M.G., Miranda K.M., Pluta R.M., Wink D.A. Nitrosative capacity of macrophages is dependent on nitricoxide synthase induction signals. J Biol Chem 2000;275(15):11341-7. DOI: 10.1074/jbc.275.15.11341. PMID: 10753947.</mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation>Ambs S., Hussain S.P., Harris C.C. Interactive effects of nitric oxide and the p53 tumor suppressor gene in carcinogenesis and tumor progression. FASEB J 1997;11(6):443-8. PMID: 9194524.</mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation>Kim Y.M., Talanian R.V., Billiar T.R. Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms. J Biol Chem 1997;272(49):31138-48. PMID: 9388267.</mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation>Kotamraju S., Tampo Y., Keszler A. et al. Nitric oxide inhibits H2O2-induced trancferrin receptor-dependent apoptosis in endothelial cells: role ubiquitin-proteasome pathway. Proc Natl Acad Sci USA 2003;100(19):10653-8. DOI: 10.1073/pnas.1933581100. PMID: 12958216.</mixed-citation></ref><ref id="B52"><label>52.</label><citation-alternatives><mixed-citation xml:lang="en">Granik V.G., Grigoriev N.B. Nitric oxide (NO). Moscow: Vuzovskaya kniga, 2004. 360 p. (In Russ.).</mixed-citation><mixed-citation xml:lang="ru">Граник В.Г., Григорьев Н.Б. Оксид азота (NO). М.: Вузовская книга, 2004. 360 с.</mixed-citation></citation-alternatives></ref><ref id="B53"><label>53.</label><mixed-citation>Crowell J.A., Steele V.E., Sigman C.C., Fay J.R. Is inducible nitric oxide synthase a target for chemoprevention? Mol Cancer Ther 2003;2(8):815-23. PMID: 12939472.</mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation>Janakiram N.B., Rao Ch.V. iNOS-selective inhibitors for cancer prevention: promise and progress. Future Med Chem 2012;4(17):2193-204. DOI: 10.4155/fmc.12.168. PMID: 23190107.</mixed-citation></ref><ref id="B55"><label>55.</label><citation-alternatives><mixed-citation xml:lang="en">Rigas B. Novel agents for cancer preven-tion based on nitric oxide. Bioch Soc Trans 2007;35(Pt5):1364-8. DOI: 10.1042/BST0351364. PMID: 17956352.</mixed-citation><mixed-citation xml:lang="ru">Rigas B. Novel agents for cancer prevention based on nitric oxide. Bioch Soc Trans 2007;35(Pt5):1364-8. DOI: 10.1042/BST0351364. PMID: 17956352.</mixed-citation></citation-alternatives></ref><ref id="B56"><label>56.</label><mixed-citation>Rao C.V., Reddy B.S, Steele V.E. et al. Nitric oxide-releasing aspirin and indomethacin are potent inhibitors against colon cancer in azoxymethane-treatedrats: effects on molecular targets. Mol Cancer Ther 2.006;5(6):1530-8. DOI: 10.1158/1535-7163.MCT-06-0061. PMID: 16818512.</mixed-citation></ref><ref id="B57"><label>57.</label><citation-alternatives><mixed-citation xml:lang="en">Deryagina V.P., Lyubchanskaya V.M., Ryzhova N.I. et al. The growth dynamics of Ehrlich carcinoma in F1 mice under the influence of NO donors — derivatives of 3-nitrobenzofuran and 3-nitroindole. Rossiyskiy bioterapevticheskiy zhurnal = Russian Biotherapeutic Journal 2009;(1):60-3. (In Russ.).</mixed-citation><mixed-citation xml:lang="ru">Дерягина В.П., Любчанская В.М., Рыжова Н.И. и др. Динамика роста карциномы Эрлиха у мышей F1 под воздействием доноров NO — производных 3-нитробензофурана и 3-нитроиндола. Российский биотерапевтический журнал 2009;(1):60-3.</mixed-citation></citation-alternatives></ref><ref id="B58"><label>58.</label><citation-alternatives><mixed-citation xml:lang="en">Deryagina V.P., Ryzhova N.I. The effect of NO synthase modulators on the growth of Ehrlich transplantable adenocarcinoma. Vestnik RONTS im. N.N. Blokhina = Bulletin of the Russian Cancer Research Center. N.N. Blokhin RAMS 2007;18(2):32-8. (In Russ.).</mixed-citation><mixed-citation xml:lang="ru">Дерягина В.П., Рыжова Н.И. Действие модуляторов NO-синтаз на рост перевивной аденокарциномы Эрлиха. Вестник РОНЦ им. Н.Н. Блохина РАМН 2007;18(2):32—8.</mixed-citation></citation-alternatives></ref><ref id="B59"><label>59.</label><citation-alternatives><mixed-citation xml:lang="en">Kashfi K., Rigas B. Molecular targets of nitric-oxide-donating aspirin in cancer. Biochem Soc Trans 2005;33(Pt):701-4. DOI: 10.1042/BST0330701. PMID: 16042578.</mixed-citation><mixed-citation xml:lang="ru">Kashfi K., Rigas B. Molecular targets of nitric-oxide-donating aspirin in cancer. Biochem Soc Trans 2005;33(Pt):701—4. DOI: 10.1042/BST0330701. PMID: 16042578.</mixed-citation></citation-alternatives></ref><ref id="B60"><label>60.</label><mixed-citation>Thomsen L.L., Scott J.M.J., Topley P. et al. Selective inhibition of inducible nitric oxide synthase inhibits tumor growth in vivo: studies with 1400 W, a novel inhibitor. Cancer Res 1997;57:3300-4. PMID: 9242464.</mixed-citation></ref><ref id="B61"><label>61.</label><mixed-citation>Tang W., Li H., Poulos T.L., Silverman R.B. Mechanistic studies of inactivation of inducible nitric oxide synthase by amidines. Biochemistry 2015;54(15):2530—8. DOI: 10.1021/acs.biochem.5b00135. PMID: 25811913.</mixed-citation></ref><ref id="B62"><label>62.</label><mixed-citation>Deryagina V.P., Ryzhova N.I., Golubkina N.A. Production of nitrogen oxide derivatives under the influence of NO-synthase inhibitors and natural compounds in mice with transplanted tumors. Exp Oncol 2012;34(1):1-5. PMID: 22453145.</mixed-citation></ref><ref id="B63"><label>63.</label><citation-alternatives><mixed-citation xml:lang="en">Deychman G.I. The role of natural resistance in the body’s response to the occurrence, growth and metastasis of tumors. Itigi nauki i tekhniki = Results of science and technology 1984;13:46-97. (In Russ.).</mixed-citation><mixed-citation xml:lang="ru">Дейчман Г.И. Роль естественной резистентности в реакции организма на возникновение, рост и метастазирование опухолей. Итоги науки и техники 1984;13:46-97.</mixed-citation></citation-alternatives></ref><ref id="B64"><label>64.</label><citation-alternatives><mixed-citation xml:lang="en">Perrotta C., Cervia D., Di Renzo I. et al. Nitric oxide generated by tumor-associated macrophages is responsible for cancer resistance to cisplatin and corelatedwith syntaxin 4 and acid sphingomyelinase inhibition. Front Immunol 2018;9:1186. DOI:10.3389/fimmu2018.01186. PMID: 29896202.</mixed-citation><mixed-citation xml:lang="ru">Perrotta C., Cervia D., Di Renzo I. et al. Nitric oxide generated by tumor-associated macrophages is responsible for cancer resistance to cisplatin and corelatedwith syntaxin 4 and acid sphingomyelinase inhibition. Front Immunol 2018;9:1186. DOI: 10.3389/fimmu2018.01186. PMID: 29896202.</mixed-citation></citation-alternatives></ref><ref id="B65"><label>65.</label><mixed-citation>Fresco P., Borges F., Diniz C., Marques M.P. New insights on the anticancer properties of dietary polyphenols. Med Res Rev 2006;26(6):7-66. DOI:10.1002/med.20060. PMID:16710860.</mixed-citation></ref><ref id="B66"><label>66.</label><citation-alternatives><mixed-citation xml:lang="en">Maldonado-Rojas W., Olivero-Verbel J. Food-related compounds that modulate expression of inducible nitric oxide synthase may act as its inhibitors. Molecules 2012;17(7):8118-35. DOI: 10.390/molecules 17078118. PMID: 22766803.</mixed-citation><mixed-citation xml:lang="ru">Maldonado-Rojas W., Olivero-Verbel J. Food-related compounds that modulate expression of inducible nitric oxide synthase may act as its inhibitors. Molecules 2012;17(7):8118-35. DOI: 10.390/molecules17078118. PMID: 22766803.</mixed-citation></citation-alternatives></ref><ref id="B67"><label>67.</label><mixed-citation>Quideau S., Deffieux D., Douat-Casassus C., Pouysegu L. Plant polyphenols: chemical properties, biological activities, and synthesis. Angew Chem Int Ed 2011;50:586-621. DOI:10.1002/anie.201000044. PMID: 21226137.</mixed-citation></ref><ref id="B68"><label>68.</label><mixed-citation>Azqueta A., Collins A. Polyphenols and DNA damage: a mixed blessing. Nutrients 2016;8(12):785. DOI: 10.3390/nu8120785. PMID: 27918471.</mixed-citation></ref><ref id="B69"><label>69.</label><citation-alternatives><mixed-citation xml:lang="en">Hara A., Okayasu I. Cyclooxygenase-2 and inducible nitric oxide synthase expression in human astrocytic gliomas: correlation with angiogenesis and prognostic significance. Acta Neuropathol 2004;108(1):43—8. DOI: 10.1007/s00401-004-0860-0. PMID: 15088099.</mixed-citation><mixed-citation xml:lang="ru">Hara A., Okayasu I. Cyclooxygenase-2 and inducible nitric oxide synthase expression in human astrocytic gliomas: correlation with angiogenesis and prognostic significance. Acta Neuropathol 2004;108(1):43-8. DOI: 10.1007/s00401-004-0860-0. PMID: 15088099.</mixed-citation></citation-alternatives></ref><ref id="B70"><label>70.</label><mixed-citation>Kim Y.A., Lim S.Y., Rhee S.H. et al. Resveratrol inhibits inducible nitric oxide synthase and cyclooxygenase-2 expression in beta-amyloid-treated C6 glioma cells. Int J Mol Med 2006;17(6):1069-75. PMID:16685418.</mixed-citation></ref><ref id="B71"><label>71.</label><mixed-citation>Holian O., Wahid S., Atten M.J., Attar B.M. Inhibition of gastric cancer cell proliferation by resveratrol: role of nitric oxide. Am J Physiol Gastrointest Liver Physiol 2002;282(5):G809-16. DOI: 10.1152/ajpgi.00193.2001. PMID: 11960777.</mixed-citation></ref><ref id="B72"><label>72.</label><mixed-citation>Notas G., Nifli A.P., Kampa M. et al. Resveratrol exerts its antiproliferative effect on HepG2 hepatocellular carcinoma cells, by inducing cell cycle arrest, and NOS activation. Biochem Biophys Acta 2006;1760:1657-66. DOI: 10.1016/j.bbagen.2006.09.010. PMID: 17052855.</mixed-citation></ref><ref id="B73"><label>73.</label><mixed-citation>Billard C., Izard J.C., Roman V. et al. Comparative antiproliferative and apoptic effects of resveratrol, epsilon viniferin and vine-shots derived polyphenols (vineatrols) on chronic B lymphocytic leukemia cells and normal human lymphocytes. Leuk Lymphoma 2002;43(10):1991-2002. DOI: 10.1080/1042819021000015952. PMID: 12481898.</mixed-citation></ref><ref id="B74"><label>74.</label><mixed-citation>Nanjoo S., Shiby P., Xingpei H. et al. Pterostilbene, an active constituent of blueberries, suppresses aberrant crypt foci formation in the azoxymethaneinduced colon carcinogenesis model inrats. Clin Cancer Research 2007;13(1):350—5. DOI: 10.1158/1078-0432.CCR-06-1528. PMID: 17200374.</mixed-citation></ref><ref id="B75"><label>75.</label><mixed-citation>Nechuta S., Shu X.O., Li H.L. et al. Prospective cohort study of tea consumption and risk of digestive system cancers: results from the Shanghai women’s health study. J Clin Nutr 2012;96(5):1056-63. DOI: 10.3945/ajcn.111.031419. PMID: 23053557.</mixed-citation></ref><ref id="B76"><label>76.</label><mixed-citation>Chan M.M., Fong D., Ho C.T., Huang H.I. Inhibition of inducible nitric oxide synthase gene expression and enzyme activity by epigallocatechin gallate, a natural product from green tea. Biochem Pharmacol 1997;54(12):1281-6. PMID: 9393670.</mixed-citation></ref><ref id="B77"><label>77.</label><citation-alternatives><mixed-citation xml:lang="en">Singh R., Ahmed S., Islam N. et al. Epigallocatechin-3-gallate inhibits interleukin-1beta-induced expression of nitric oxide synthase and production of nitric oxide in human chondrocytes: suppression of nuclear factor kappaB activation by degradation of the inhibitor of nuclear factor kappaB. Arthritis Rheum 2002;46(8):2079-86. DOI: 10.1002/art.10443. PMID: 12209512.</mixed-citation><mixed-citation xml:lang="ru">Singh R., Ahmed S., Islam N. et al. Epigallocatechin-3-gallate inhibits interleukin-1beta-induced expression of nitric oxide synthase and production of nitric oxide in human chondrocytes: suppression of nuclear factor kappa B activation by degradation of the inhibitor of nuclear factor kappaB. Arthritis Rheum 2002;46(8):2079-86. DOI: 10.1002/art.10443. PMID: 12209512.</mixed-citation></citation-alternatives></ref><ref id="B78"><label>78.</label><mixed-citation>Salmani J.M.M., Zhang X.P., Jacob J.A., Chen B.A. Apigenin’s anticancer properties and molecular mechanisms of action: recent advances and future prospectives. Chin J Natur Med 2017;15(5):321-9. DOI: 10.1016/S1875-5364(17)30052-3. PMID: 28558867.</mixed-citation></ref><ref id="B79"><label>79.</label><mixed-citation>Shankar E., Goel A., Gupta K., Gupta S. Plant flavone apigenin: an emerging anticancer agent. Curr Pharmacol Rep 2017;3(6):423-46. DOI: 10.1007/s40495-017-0113-2. PMID: 29399439.</mixed-citation></ref><ref id="B80"><label>80.</label><mixed-citation>Chen J., Chen A.Y., Huang H. et al. The flavonoid nobiletin inhibits tumor growth and angiogenesis of ovarian cancer via the Akt pathway. Int J Oncol 2015;46(6): 2629-38. DOI: 10.3892/ijo.2015.2946. PMID: 25845666.</mixed-citation></ref><ref id="B81"><label>81.</label><mixed-citation>Nishino H., Tokuda H., Satomi Y. et al. Cancer prevention by antioxidants. Biofactors 2004;22(1—4):57-61. PMID: 15630252.</mixed-citation></ref><ref id="B82"><label>82.</label><mixed-citation>Applegate C.C., Rowles J.L., Ranard K.M. et al. Soy consumption and risk of prostate cancer: an updated systematic review and meta-analysis. Nutrients 2018;10(1). DOI: 10.3390/nu10010040. PMID: 29300347.</mixed-citation></ref><ref id="B83"><label>83.</label><mixed-citation>Ravindranath M.H., Muthugounder S., Presser N., Viswanathan S. Anticancer therapeutic potential of soy isoflavone, genestein. Adv Exp Med Biol 2004;546(1):121-65. PMID: 15584372.</mixed-citation></ref><ref id="B84"><label>84.</label><mixed-citation>Feinstein D.L., Galea E., Cermak J. et al. Nitric oxide synthase expression in glial cells: suppression by tyrosine kinase inhibitors. J Neurochem 1994;62(2):811-4. PMID: 7507517.</mixed-citation></ref><ref id="B85"><label>85.</label><mixed-citation>Faried A., Kurnia D., Faried L.S. et al. Anticancer effects of gallic acid isolated from Indonesian herbal medicine, Phaleria macrocarpa (Scheff.) Boerl, on human cancer cell lines. Int J Oncol 2007;30(3):605-13. PMID: 17273761.</mixed-citation></ref><ref id="B86"><label>86.</label><mixed-citation>Sourani Z., Pourgheysari B., Beshkar P. et al. Gallic acid inhibits proliferation and induces apoptosis in lymphoblastic leukemia cell line (C121). Iran J Med Sci 2016;41(6):525-30. PMID: 27853333.</mixed-citation></ref><ref id="B87"><label>87.</label><citation-alternatives><mixed-citation xml:lang="en">Antoshina E.E., Gorkova T.G., Deryagina V.P., Ryzhova N.I. The inhibitory effect of phenolic acids and various forms of microalgae spirulina on the growth of Ehrlich carcinoma in mice. Vestnik RONTS im. N.N. Blokhina = Bulletin RCRC them. N.N. Blokhin RAMS 2009;20(4):26-31. (In Russ.).</mixed-citation><mixed-citation xml:lang="ru">Антошина Е.Е., Горькова Т.Г., Дерягина В.П., Рыжова Н.И. Ингибирующее действие фенольных кислот и разных форм микроводоросли спирулины на рост карциномы Эрлиха у мышей. Вестник РОНЦ им. Н.Н Блохина РАМН 2009;20(4):26-31.</mixed-citation></citation-alternatives></ref><ref id="B88"><label>88.</label><citation-alternatives><mixed-citation xml:lang="en">Sun Z., Zhou C., Liu F. et al. Inhibition of breast cancer cell survival by xanthohumol via modulation of the Notch signaling pathway in vivo and in vitro. Oncol Lett 2018;15(1):908-16. DOI: 10.3892/ol.2017.7434. PMID: 29422966.</mixed-citation><mixed-citation xml:lang="ru">Sun Z., Zhou C., Liu F. et al. Inhibition of breast cancer cell survival by xanthohumol via modulation of the Notch signaling pathway in vivo and in vitro. Oncol Lett 2018;15(1):908—16. DOI: 10.3892/ol.2017.7434. PMID: 29422966.</mixed-citation></citation-alternatives></ref><ref id="B89"><label>89.</label><mixed-citation>Gerhauser C., Alt A., Heiss E. et al. Cancer chemopreventive activity of Xanthohumol, a natural product derived from hop. Mol Cancer Ther 2002;1(11):959-69. PMID: 12481418.</mixed-citation></ref><ref id="B90"><label>90.</label><citation-alternatives><mixed-citation xml:lang="en">Kravchenko L.V., Morozov S.V., Deryagina V.P. et al. Antioxidant status of rats treated with different amounts of lycopene. Byulleten’ eksperimental’noy biologii i meditsiny = Bulletin of Experimental Biology and Medicine 2003;135(4):414-8. (In Russ.).</mixed-citation><mixed-citation xml:lang="ru">Кравченко Л.В., Морозов С.В., Дерягина В.П. и др. Антиоксидантный статус крыс, получавших разное количество ликопина. Бюллетень экспериментальной биологии и медицины 2003;135(4):414-8.</mixed-citation></citation-alternatives></ref><ref id="B91"><label>91.</label><mixed-citation>Holzapfel N.P., Shokoohmand A., Wagner F. et al. Lycopene reduced ovarian tumor growth and intraperitoneal metastatic load. Am J Cancer Res 2017;7(6):1322-36. PMID: 28670494.</mixed-citation></ref><ref id="B92"><label>92.</label><citation-alternatives><mixed-citation xml:lang="en">Liu Y., Bi T., Shen G. et al. Lupeol induces apoptosis and inhibits invasion in gallbladder carcinoma GBC-SD cells by suppression of EGFR/MMP9 signaling pathway. Cytotechnology 2016;68(1):123-33. DOI: 10.1007/s10616-014-9763-7. PMID: 25037728.</mixed-citation><mixed-citation xml:lang="ru">Liu Y., Bi T., Shen G. et al. Lupeol induces apoptosis and inhibits invasion in gallbladder carcinoma GBC-SD cells by suppression of EGFR/MMP9 signaling pathway. Cytotechnology 2016;68(1):123—33. DOI: 10.1007/s10616-014-9763-7. PMID: 25037728.</mixed-citation></citation-alternatives></ref><ref id="B93"><label>93.</label><citation-alternatives><mixed-citation xml:lang="en">Liu Y., Bi T., Wang G. et al. Lupeol inhibits proliferation and induces apoptosis of human pancreatic cancer PCNA-1 cells through AKT/ERK pathways. Naunyn Schmiedebergs Arch Pharm 2015;388(3):295—304. DOI: 10.1007/s00210-014-1071-4. PMID: 25418891.</mixed-citation><mixed-citation xml:lang="ru">Liu Y., Bi T., Wang G. et al. Lupeol inhibits proliferation and induces apoptosis of human pancreatic cancer PCNA-1 cells through AKT/ERK pathways. Naunyn Schmiedebergs Arch Pharm 2015;388(3):295-304. DOI: 10.1007/s00210-014-1071-4. PMID: 25418891.</mixed-citation></citation-alternatives></ref><ref id="B94"><label>94.</label><mixed-citation>Saleem M., Afaq F., Adhami V.M. et al. Lupeol modulates NF-kappaB and PI3K/ Akt pathways and inhibits skin cancer in CD-1 mice. Oncogene 2004;23(300): 5203-14. DOI: 10.1038/sj.onc.120764. PMID: 15122342.</mixed-citation></ref><ref id="B95"><label>95.</label><mixed-citation>Higdon J.V., Delage B., Williams D.E., Dashwood R.H. Cruciferous vegetables and human cancer risk: epidemiologic evidence and mechanistic basis. Pharm Res 2007;55: 224-36. DOI: 10.1016/j.phrs.2007.01.009. PMID: 17317210.</mixed-citation></ref><ref id="B96"><label>96.</label><mixed-citation>Megna B.W., Carney P.R., Nukaya M. et al. Indole-3-carbinol induces tumor cell death: function follows form. J Surg Res 2016;204(1):47-54. DOI: 10.1016/j.jss.2016.04.021. PMID: 27451867.</mixed-citation></ref><ref id="B97"><label>97.</label><citation-alternatives><mixed-citation xml:lang="en">Deryagina V.P., Ryzhova N.I. Effect of flavonoids and indoles on the growth of adenocarcinoma in mice. Vestnik RONTS im. N.N. Blokhina = Bulletin RCRC them. N.N. Blokhin RAMS 2009;20(1):10-5. (In Russ.).</mixed-citation><mixed-citation xml:lang="ru">Дерягина В.П., Рыжова Н.И. Влияние флавоноидов и индолов на рост аденокарциномы у мышей. Вестник РОНЦ им. Н.Н. Блохина 2009;20(1):10-5.</mixed-citation></citation-alternatives></ref><ref id="B98"><label>98.</label><mixed-citation>Bunaciu R.P., Yen A. Retinoid chemoprevention: who can benefit? Curr Pharmacol Rep 2015;1(6):391 —400. DOI: 10.1007/s40495-015-0036-8. PMID: 26539342.</mixed-citation></ref><ref id="B99"><label>99.</label><mixed-citation>Simile M.M., Pagnan G., Pastorino F. et al. Chemopreventive N-(4-hydroxy-phenyl)retinamide (fenretinide) targets deregulated NF-{kappa}B and Mat1A genes in the early stages of rat liver carcinogenesis. Carcinogenesis 2005;26(2):417-27. DOI: 10.1093/carcin/bgh315. PMID: 15498786.</mixed-citation></ref><ref id="B100"><label>100.</label><mixed-citation>Rafa H., Benkhelifa S., Younes S.A. et al. All-trans retinoic acid modulates TLR4/ NF-KB signaling pathway targeting TNF-a and nitric oxide synthase 2 expression in colonic mucosa during ulcerative colitis and colitis associated cancer. Mediators Inflamm 2017;2017:7353252. DOI: 10.1155/2017/7353252. PMID: 28408791.</mixed-citation></ref><ref id="B101"><label>101.</label><mixed-citation>Simeone A.M., Colella S., Krahe R. et al. N-(4-Hydroxyphenyl)retinamide and nitric oxide pro-drugs exhibit apoptotic and anti-invasive effects against bone metastatic breast cancer cells. Carcinogenesis 2006;27(3):568-77. DOI: 10.1093/carcin/bgi233. PMID: 16199439.</mixed-citation></ref><ref id="B102"><label>102.</label><mixed-citation>Stephenson J.A., Al-Taan O., Arshad A. et al. The multifaceted effects of omega-3 polyunsaturated fatty acids on the hallmarks of cancer. J Lipids 2013. DOI: 10.1155/2013/261247. PMID: 23762563.</mixed-citation></ref><ref id="B103"><label>103.</label><mixed-citation>Gu Zh., Shan K., Chen H., Chen Y.Q. n-3 polyunsaturated fatty acids and their rolein cancer chemoprevention. Curr Pharmacol Rep 2015;1(5):283-94. DOI: 10.1007/s40495-015-0043-9. PMID: 26457243.</mixed-citation></ref><ref id="B104"><label>104.</label><mixed-citation>Wink D.A., Vodovoz Y., Laval J. et al. The multifaceted roles of nitric oxide in cancer. Carcinogenesis 1998;19(5):711-21. PMID: 9635855.</mixed-citation></ref><ref id="B105"><label>105.</label><citation-alternatives><mixed-citation xml:lang="en">Ohata T., Fukuda K., Takahashi M. et al. Supression of nitric oxide production in lipopolysaccharide-stimulated macro-phage cells by omega 3 polyunsaturated fatty acids. Japan J Cancer Res 1997;88(3):234—7. PMID: 9140106.</mixed-citation><mixed-citation xml:lang="ru">Ohata T., Fukuda K., Takahashi M. et al. Supression of nitric oxide production in lipopolysaccharide-stimulated macro-phage cells by omega 3 polyunsaturated fatty acids. Japan J Cancer Res 1997;88(3):234-7. PMID: 9140106.</mixed-citation></citation-alternatives></ref><ref id="B106"><label>106.</label><mixed-citation>Narayanan B.A., Narayanan N.K., Simi B., Reddy B.S. Modulation of inducible nitric oxide synthase and related proinflammatory genes by the omega-3 fatty acid docosahexaenoic acid in human colon cancer cells. Cancer Res 2003;63(5):972-9. PMID: 12615711.</mixed-citation></ref><ref id="B107"><label>107.</label><mixed-citation>Narayanan BA., Narayanan N.K., Desai D. et al. Effects of a combination of docosahexaenoic acid and 1,4-phenylene bis (methylene) selenocyanate on cyclooxygenase 2, inducible nitric oxide synthase and beta-catenin pathways in colon cancer cells. Carcinogenesis 2004;25(12):2443-9. PMID: 15297372. DOI: 10.1093/carcin/bgh252.</mixed-citation></ref><ref id="B108"><label>108.</label><citation-alternatives><mixed-citation xml:lang="en">Serini S., Calviello G. Modulation of Ras/ERK and phosphoinositide signaling by long-chain n-3 PUFA in breast cancer and their potential complementary role in combination with targeted drugs. Nutrients 2017;9(3):185. DOI:10.3390/nu9030185. PMID: 28241486.</mixed-citation><mixed-citation xml:lang="ru">Serini S., Calviello G. Modulation of Ras/ERK and phosphoinositide signaling by long-chain n-3 PUFA in breast cancer and their potential complementary role in combination with targeted drugs. Nutrients 2017;9(3):185. DOI: 10.3390/nu9030185. PMID: 28241486.</mixed-citation></citation-alternatives></ref><ref id="B109"><label>109.</label><mixed-citation>Galley H.F., Walker B.E., Howdle P.D., Webster N.R. Regulation of nitric oxide synthase activity in cultured human endothelial cells: effect of antioxidants. Free Radic Biol Med 1996;21(1):97-101. PMID: 8791097.</mixed-citation></ref><ref id="B110"><label>110.</label><mixed-citation>Mazhar K., Yang Y., Wang Sh. et al. Role of vitamin E in prevention of human esophageal squamous cell carcinoma: a review. Sci Lett 2015;3:89-93.</mixed-citation></ref><ref id="B111"><label>111.</label><mixed-citation>Calvisi D.F., Ladu S., Hironaka K. et al. Vitamin E down-modulates iNOS and NADPH in c-Myc/TGF-alpha transgenic mouse model of liver cancer. J Hepatol 2004;41(5):815-22. DOI: 10.1016/j.jhep.2004.07.030. PMID: 15519655.</mixed-citation></ref><ref id="B112"><label>112.</label><mixed-citation>Mandl J., Szarka A., Banhegyi G. Vitamin C: update on physiology and pharmacology. Br J Pharmacol 2009;157(7):1097-110. DOI: 10.1111/j.1476-5381.2009.00282.x. PMID: 19508394.</mixed-citation></ref><ref id="B113"><label>113.</label><mixed-citation>Mayland C.R., Bennett M.I., Allan K. Vitamin C deficiency in cancer patients. Palliat Med 2005;19:17-20. DOI: 10.1191/0269216305pm970oa. PMID: 15690864.</mixed-citation></ref><ref id="B114"><label>114.</label><mixed-citation>Wu F., Wilson J.X., Tyml K. Ascorbate inhibits iNOS expression and preservesvasoconstrictor responsiveness in skeletal muscle of septic mice. Am J Physiol Regul Integr Comp Physiol 2003;285(1):50-6. DOI: 10.1152/ajpregu.00564.2002. PMID: 12637347.</mixed-citation></ref><ref id="B115"><label>115.</label><mixed-citation>Ichim Th.E., Minev B., Braciak T. et al. Intravenous ascorbic acid to prevent and treat cancer-associated sepsis? J Transl Med 2011. DOI: 10.1186/1479-5876-9-25. PMID: 21375761.</mixed-citation></ref><ref id="B116"><label>116.</label><citation-alternatives><mixed-citation xml:lang="en">Li R. Vitamin C, a multi-tasking molecule, find a molecular target in killing cancer cells. React Oxyg Species (Apex) 2016;1(2):141—56. DOI: 10.20455/ros.2016.829. PMID: 29780883.</mixed-citation><mixed-citation xml:lang="ru">Li R. Vitamin C, a multi-tasking molecule, find a molecular target in killing cancer cells. React Oxyg Species (Apex) 2016;1(2):141-56. DOI: 10.20455/ros.2016.829. PMID: 29780883.</mixed-citation></citation-alternatives></ref><ref id="B117"><label>117.</label><mixed-citation>Bartsch H., Frank N. Blocking the endogenous formation of N-nitroso compounds and related carcinogens. IARC Sci Publ 1996;139:189-201. PMID: 8923031.</mixed-citation></ref><ref id="B118"><label>118.</label><citation-alternatives><mixed-citation xml:lang="en">Zhukova G.F., Mikhailova M.V Reducing the level of N-nitrosamine contamination of animal products: survey information. Moscow: VNIITEIagroprom, 1989. 45 p. (In Russ.).</mixed-citation><mixed-citation xml:lang="ru">Жукова Г.Ф., Михайлова М.В. Снижение уровня загрязненности N-нитрозаминами продуктов животного происхождения: обзорная информация. М.: ВНИИТЭИагропром, 1989. 45 с.</mixed-citation></citation-alternatives></ref><ref id="B119"><label>119.</label><citation-alternatives><mixed-citation xml:lang="en">Deryagina V.P., Zhukova G.F., Vlaskina S.G. et al. Effect of selenium on the formation of carcinogenic N-nitrosamines. Voprosy pitaniya = Nutrition Issues 1996;3:31-3. (In Russ.).</mixed-citation><mixed-citation xml:lang="ru">Дерягина В.П., Жукова Г.Ф., Власкина С.Г. и др. Влияние селена на образование канцерогенных N-нитрозоаминов. Вопросы питания 1996;3:31-3.</mixed-citation></citation-alternatives></ref><ref id="B120"><label>120.</label><citation-alternatives><mixed-citation xml:lang="en">Khotimchenko S.A., Zhukova G.F., Deryagina V.P., Golubkina N.A. Inhibitory effect of selenium on the endogenous synthesis of N-nitroso compounds in rats. Voprosy pitaniya = Nutrition Issues 1997;4:16-8. (In Russ.).</mixed-citation><mixed-citation xml:lang="ru">Хотимченко С.А., Жукова Г.Ф., Дерягина В.П., Голубкина Н.А. Ингибирующее действие селена на эндогенный синтез N-нитрозосоединений у крыс. Вопросы питания 1997;4:16-8.</mixed-citation></citation-alternatives></ref><ref id="B121"><label>121.</label><mixed-citation>Bingham S.A., Hughes R., Cross A.J. Effect of white versus red meat on endogenous N-nitrosation in the human colon and further evidence of a dose response. J Nutr 2002;132:3522S-5S. DOI: 10.1093/jn/132.11.3522S. PMID: 12421881.</mixed-citation></ref><ref id="B122"><label>122.</label><mixed-citation>Bingham S. Meat, starch and non-starch polysaccharides, are epidemiological and experimental findings consistent with acquired genetic alterations in sporadic colorectal cancer? Cancer Lett 1997;114(1, 2):25-34. PMID: 9103247.</mixed-citation></ref><ref id="B123"><label>123.</label><mixed-citation>Lewin M.H., Bailey N., Bandaletova T. et al. Red meat enhances the colonic formation of the DNA adduct O6-carboxymethyl guanine: implications for colorectal cancer risk. Cancer Res2006;66(3):1859-65. DOI: 10.1158/0008-5472.CAN-05-2237. PMID: 16452248.</mixed-citation></ref><ref id="B124"><label>124.</label><mixed-citation>Hughes R., Pollock J.R., Bingham S. Effect of vegetables, tea and soy on endogenous N-nitrosation, fecal ammonia, and fecal water genotoxicity during a high red meat diet in humans. Nutr Cancer 2002;42(1):70-7. DOI: 10.1207/S15327914NC421_10. PMID: 12235653.</mixed-citation></ref><ref id="B125"><label>125.</label><mixed-citation>Mirvish S.S., Haorah J., Zhou L. et al. Total N-nitroso compounds and their precursors in hot dogs and in the gastro-intestinal tract and feces of rats and mice: possible etiologic agents for colon cancer. J Nutr 2002;132:3526S-9S. DOI: 10.1093/jn/132.11.3526S. PMID: 12421882.</mixed-citation></ref><ref id="B126"><label>126.</label><mixed-citation>Cross A.J., Greetham H.L., Pollock J.R. et al. Variability in fecal water genotoxicity, determined using the Comet assay, is independent of endogenous N-nitroso compound formation attributed to red meat consumption. Environ Mol Mutagen 2006;47(3):179-84. DOI: 10.1002/em.20181. PMID: 16304669.</mixed-citation></ref><ref id="B127"><label>127.</label><citation-alternatives><mixed-citation xml:lang="en">Zhukova G.F. Development of methodical approaches of hygienic control over the content of N-nitroso compounds in food products, the study of the patterns of their formation and ways to reduce the entry into the human body. Thesis ... of doctor of biological science. Moscow, 1990. 355 p. (In Russ.).</mixed-citation><mixed-citation xml:lang="ru">Жукова Г.Ф. Разработка методических подходов гигиенического контроля за содержанием в пищевых продуктах N-нитрозосоединений, изучение закономерностей их образования и способов снижения поступления в организм человека. Дис. ... д-ра биол. наук. М., 1990. 355 с.</mixed-citation></citation-alternatives></ref><ref id="B128"><label>128.</label><mixed-citation>Myte R., Gylling B., Haggstrom J. et al. Untangling the role of onecarbon metabolism in colorectal cancer risk: a comprehensive Bayesian network analysis. Sci Rep 2017;7:43434. PMID: 28233834. DOI:10.1038/strep43434.</mixed-citation></ref><ref id="B129"><label>129.</label><mixed-citation>Eizirik D.L., Sandler S., Welsh N. et al. Nicotinamide decreases nitric oxide production and partially protects human pancreatic islets against the suppressive effects of combinations of cytokines. Autoimmunity 1994;19(3):193-8. PMID: 7605871.</mixed-citation></ref><ref id="B130"><label>130.</label><citation-alternatives><mixed-citation xml:lang="en">Komatsu S., Yanaka N., Matsubara K. et al. Antitumor effect of vitamin B6 and its mechanisms. Biochim Biophys Acta 2003;1647(1-2):127-30. PMID: 12686121.</mixed-citation><mixed-citation xml:lang="ru">Komatsu S., Yanaka N., Matsubara K. et al. Antitumor effect of vitamin B6 and its mechanisms. Biochim Biophys Acta 2003;1647(1—2):127-30. PMID: 12686121.</mixed-citation></citation-alternatives></ref><ref id="B131"><label>131.</label><mixed-citation>Robertson M.A., Finochietto P., Gamba C.A. Nicotinamide increases thyroid radiosensitivity by stimulating nitric oxide synthase expression and the generation of organic peroxides. Horm Metab Res 2006;38(1):12-5. DOI: 10.1055/s-2006-924966. PMID: 16477534.</mixed-citation></ref><ref id="B132"><label>132.</label><mixed-citation>Petrovic V., Nepal A., Olaisen C. et al. Anti-cancer potential of homemade fresh garlic extract is related to increased endoplasmic reticulum stress. Nutrients 2018;10(4):450. DOI: 10.3390/nu10040450. PMID: 29621132.</mixed-citation></ref><ref id="B133"><label>133.</label><mixed-citation>Nishikawa-Ogawa M., Wanibuchi H., Morimura K. et al. N-acetylcysteine and S-methylcysteine inhibit MeIQx rat hepatocarcinogenesis in the post-initiation stage. Carcinogenesis 2005;27(5):982-8. DOI: 10.1093/carcin/bgi277. PMID: 16338951.</mixed-citation></ref><ref id="B134"><label>134.</label><mixed-citation>Ansari F.A., Khan A.A., Mahmood R. Protective effect of carnosine and N-acetylcysteine against sodium nitrite-induced oxidative stress and DNA damage in rat intestine. Environ Sci Pollut Res Int 2018;25(20):19380-92. DOI: 10.1007/s11356-018-2133-9. PMID: 29728968.</mixed-citation></ref><ref id="B135"><label>135.</label><mixed-citation>Bruns H., Kazanavicius D., Schultze D. et al. Glycine inhibits angiogenesis in colorectal cancer: role of endothelial cells. Amino Acids 2016;48(11):2549-58. DOI: 10.1007/s00726-016-2278-0. PMID: 27351202.</mixed-citation></ref><ref id="B136"><label>136.</label><citation-alternatives><mixed-citation xml:lang="en">Weinberg J.M., Bienholz A., Venkatachalam M.A. The role of glycine in regulated cell death. Cell Mol Life Sci 2016;73(11 —12):2285-308. DOI: 10.1007/s00018-016-2201-6. PMID: 27066896.</mixed-citation><mixed-citation xml:lang="ru">Weinberg J.M., Bienholz A., Venkatachalam M.A. The role of glycine in regulated cell death. Cell Mol Life Sci 2016;73(11-12):2285-308. DOI: 10.1007/s00018-016-2201-6. PMID: 27066896.</mixed-citation></citation-alternatives></ref><ref id="B137"><label>137.</label><mixed-citation>Rose M.L., Cattley R.C., Dunn C. et al. Dietary glycine prevents the development of liver tumors caused by the peroxisome proliferator WY-14,643. Carcinogenesis 1999;20(11):2075-81. PMID: 10545408.</mixed-citation></ref><ref id="B138"><label>138.</label><mixed-citation>Amin K., Li J., Chao W.R. et al. Dietary glycine inhibits angiogenesis during wound healing and tumor growth. Cancer Biol Ther 2003;2(2):173-8. PMID: 12750558.</mixed-citation></ref><ref id="B139"><label>139.</label><mixed-citation>Maddocks O.D.K., Athineos D., Cheung E.C. et al. Modulating the therapeutic response of tumours to dietary serine and glycine starvation. Nature 2017;544(7650): 372-6. DOI: 10.1038/nature22056. PMID: 28425994.</mixed-citation></ref><ref id="B140"><label>140.</label><mixed-citation>Lijima K., Shimosegawa T. Involvement of luminal nitric oxide in the pathogenesis of the gastroesophageal reflux disease spectrum. J Gastroenter Hepatol 2014;29:898-905. DOI: 10.1111/jgh.12548. PMID: 24863184.</mixed-citation></ref><ref id="B141"><label>141.</label><mixed-citation>Kumagai H., Mukaisho K., Sugihara H. et al. Thioproline inhibits development of esophageal adenocarcinoma induced by gastroduodenal reflux in rats. Carcinogenesis 2004;25(5):723-7. DOI: 10.1093/carcin/bgh067. PMID: 14754873.</mixed-citation></ref><ref id="B142"><label>142.</label><mixed-citation>Oyagbemi A.A., Saba A.B., Ibraheem A.O. Curcumin: from Food Spice to cancer prevention. Asian Pacific J Cancer Prev 2009;10:963-7. PMID: 20192567.</mixed-citation></ref><ref id="B143"><label>143.</label><mixed-citation>Siddapa G., Kulsum S., Ravindra D.R. et al. Curcumin and metformin mediated chemoprevention of oral cancer is associated with inhibition of cancer stem cells. Mol Carcinog 2017;56(11):2446-60. DOI: 10.1002/mc.22692. PMID: 28618017.</mixed-citation></ref><ref id="B144"><label>144.</label><citation-alternatives><mixed-citation xml:lang="en">Belitsky G.A., Kirsanov K.I., Lesovaya E.A., Yakubovskaya M.G. Natural inhibitors of carcinogenesis. In: Molecular carcinogenesis. Moscow: ABV-press, 2016. Pp. 158-177. (In Russ.).</mixed-citation><mixed-citation xml:lang="ru">Белицкий Г.А., Кирсанов К.И., Лесовая Е.А., Якубовская М.Г. Природные ингибиторы канцерогенеза. Молекулярный канцерогенез. М.: АБВ-пресс, 2016. С. 158-177.</mixed-citation></citation-alternatives></ref><ref id="B145"><label>145.</label><mixed-citation>Cherdantseva L.A., Potapova O.V., Scarcova T.V. et al. Association of Helicobacter pylori and iNOS production by JMJ macrophages and lymphocytes in the gastric mucosa in chronic gastritis. J Immunol Res 2014;2014:762514. DOI: 10.1155/2014/762514. PMID: 25309933.</mixed-citation></ref><ref id="B146"><label>146.</label><mixed-citation>Itzkowitz S.H., Yio X. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol 2004;287:G7-17. DOI: 10.1152/ajpgi.00079.2004. PMID: 15194558.</mixed-citation></ref><ref id="B147"><label>147.</label><mixed-citation>Hussain S.P., He P., Subleski J. et al. Nitric oxide is a key component in inflammation-accelerated tumorigenesis. Cancer Res 2008;68(17):7130-6. DOI: 10.1158/0008-5472.CAN-08-0410. PMID: 18757428.</mixed-citation></ref><ref id="B148"><label>148.</label><mixed-citation>Roxburgh C.S.D., McMillan D.C. Cancer and systemic inflammation: treat the tumor and treat the host. Br J Cancer 2014;110(6):1409-12. DOI: 10.1038/bjc.2014.90. PMID: 24548867.</mixed-citation></ref><ref id="B149"><label>149.</label><mixed-citation>Vahora H., Khan M.A., Alalami U., Hussain A. The potential role of nitric oxide in halting cancer progression through chemoprevention. J Cancer Prevention 2016;21:1-12. DOI: 10.15430/JCP.2016.21.1.1. PMID: 27051643.</mixed-citation></ref><ref id="B150"><label>150.</label><mixed-citation>Kleinert H., Euchenhofer C., Ihrig-Biedert I., Forstermann U. Glucoco-rticoids inhibits the induction of nitric oxide synthase II by down-regulating cytokine-induced activity of transcription factor nuclear factor-kappa B. Mol Pharmacol 1996;49:15-21. PMID: 8569701.</mixed-citation></ref><ref id="B151"><label>151.</label><citation-alternatives><mixed-citation xml:lang="en">Tedeschi E., Menegazzi M., Margotto D. et al. Anti-inflammatory actions of St. John’s wort: inhibition of human inducible nitric-oxide synthase expression by down¬regulating signal transducer and activator of transcription-1alpha (STAT-1alpha) activation. J Pharmacol Exp Ther 2003;307(1):254-61. DOI: 10.1124/jpet.103.054460. PMID: 12954801.</mixed-citation><mixed-citation xml:lang="ru">Tedeschi E., Menegazzi M., Margotto D. et al. Anti-inflammatory actions of St. John’s wort: inhibition of human inducible nitric-oxide synthase expression by down-regulating signal transducer and activator of transcription-1alpha (STAT-1alpha) activation. J Pharmacol Exp Ther 2003;307(1):254-61. DOI: 10.1124/jpet.103.054460. PMID: 12954801.</mixed-citation></citation-alternatives></ref><ref id="B152"><label>152.</label><mixed-citation>Galati G., O’Brien P. Potential toxicity of flavonoids and other dietary phenolics: significance for their chemopreventive and anticancer properties. Free Radic Biol Med 2004;37:287-303. DOI: 10.1016/j.freeradbiomed.2004.04.034. PMID: 15223063.</mixed-citation></ref><ref id="B153"><label>153.</label><mixed-citation>Suresh D. Srinivasan K. Tissue distribution &amp; elimination of capsaicin, piperine&amp;curcumin following oral intake in rats. Indian J Med Research 2010;131:682-91. PMID: 20516541.</mixed-citation></ref><ref id="B154"><label>154.</label><citation-alternatives><mixed-citation xml:lang="en">Deryagina V.P., Ryzhova N.I., Golubkina N.A. et al. Experimental study of the preventive properties of plant-enriched selenium products on a model of transplantable tumors in mice. Voprosy biologicheskoy, mrditsinskoy i farmakologicheskoy = Questions of Biological, Medical and Pharmacological chemistry 2011;11:49-55.(In Russ.).</mixed-citation><mixed-citation xml:lang="ru">Дерягина В.П., Рыжова Н.И., Голубки-на Н.А. и др. Экспериментальное изучение профилактических свойств обогащенных селеном растительных продуктов на модели перевиваемых опухолей у мышей. Вопросы биологи-ческой, медицинской и фармакологической химии 2011;11:49-55.</mixed-citation></citation-alternatives></ref><ref id="B155"><label>155.</label><citation-alternatives><mixed-citation xml:lang="en">Zhou Y., Zheng J., Li Y. et al. Natural polyphenols for prevention and treatment of cancer. Nutrients 2016;8(8):515. PMID: 27556486. DOI:10.3390/nu808051.</mixed-citation><mixed-citation xml:lang="ru">Zhou Y., Zheng J., Li Y. et al. Natural polyphenols for prevention and treatment of cancer. Nutrients 2016;8(8):515. PMID: 27556486. DOI: 10.3390/nu808051.</mixed-citation></citation-alternatives></ref><ref id="B156"><label>156.</label><citation-alternatives><mixed-citation xml:lang="en">Lyashenko A.A., Miroshnichenko I.I., Oganesyan E.A. Increased systemic bioavailability of transresveratrol using nanoparticles. Khimiko-farmatsevticheskii zhurnal = Chemical Pharmaceutical Journal 2010;2:25-8. (In Russ.).</mixed-citation><mixed-citation xml:lang="ru">Ляшенко А.А., Мирошниченко И.И., Оганесян Е.А. Повышение системной биодоступности трансрезвератрола с использованием наночастиц. Химико-фармацевтический журнал 2010;2:25-8.</mixed-citation></citation-alternatives></ref><ref id="B157"><label>157.</label><mixed-citation>Khushnud T., Mousa Sh.A. Potential role of naturally derived polyphenols and their nanothechnology delivery in cancer. Mol Biotechnol 2013;55:78-86. DOI: 10.1007/s12033-012-9623-7. PMID: 23371307.</mixed-citation></ref><ref id="B158"><label>158.</label><mixed-citation>Nosrati N., Bacovic M., Paliyath G. Molecular mechanisms and pathways as targets for cancer prevention and progression with dietary compounds. Int J Mol Sci 2017;18(10):2050. DOI: 10.3390/ijms18102050. PMID: 28946660.</mixed-citation></ref></ref-list></back></article>
